Key Clinical Insights Semaglutide aids glucose control via GLP-1 receptor agonism
She conducts research on how patients access care, and those who are uncomfortable with digital tools like using apps and emailing their doctors are not receiving the same level of care and the same access to popular new weight loss drugs as those who are tech savvy and comfortable advocating for themselves
GCN2iB increases left ventricular ejection fraction, while reducing fasting blood glucose and myocardial fibrosis
Other symptoms are neurological and may include tingling in the extremities, confusion, memory loss, depression and difficulty maintaining balance
Sam was amazing like always
After blocking with 5% BSA in TBST, slides were stained with rat anti-BrdU antibody (which detects CldU but not IdU, OBT0030, 1:2000, AbDSerotec) and mouse anti-BrdU antibody (which detects IdU but not CldU, 7580, 1:1000, BD Biosciences) at 4 C for overnight